NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/28/2024
Back to search
Official data from USPTO
NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION
ST13
US500000098149193Class
42
Filing
98149193
Registration
7401968
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
05/28/2024
Trademark type
Word
Nice classes
42
Filing date
08/24/2023
Registration date
05/28/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2024
Last transaction
05/28/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/19/2021
First use in commerce
10/19/2021
Drawing code
4
Owner type
03
Owner location
Cazenovia, NY, US
Examiner
AGOSTO, GISELLE MARIE
Law office
L20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
National Community Oncology Dispensing Association, Inc.
Representatives
Jeffrey Mustari, Esq. SOUTHERN HEALTH LAWYERS, LLC (A SANDERS & MUSTARI
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Developing accreditation standards for dispensing pharmacy within an oncology center of excellence to the order and specification of others; Evaluating organizations to determine whether the organizations conform to an established accreditation standard; Testing and evaluating accreditation standards for dispensing pharmacy within an oncology center of excellence to the order and specification of others; Testinganalysis and evaluation of service providers to determine conformity with established accreditation standards; Testinganalysis and evaluation of dispensing pharmacy within an oncology center of excellence to determine conformity with established accreditation standards
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2023
GNRT
NON-FINAL ACTION E-MAILED
11/03/2023
CNRT
NON-FINAL ACTION WRITTEN
11/03/2023
DOCK
ASSIGNED TO EXAMINER
10/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/25/2023
NWAP
NEW APPLICATION ENTERED
08/28/2023
Continuous trademark protection
Get notified about every new filing that threatens NCODA CENTER OF EXCELLENCE MEDICALLY INTEGRATED PHARMACY ACCREDITATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.